Search clinical trials for: inhaler

Total 1443 results

Tufts Medical Center

Completed

Increased Ketorolac Administration After Cesarean Section and Its Effect on Opioid Use: a Randomized Control Trial

Cesarean Section Complications | Post-operative Pain | Post-partum Pain

United States
Goethe University
German Federal Ministry of Education and Research; Deutsche Krebshilfe e.V....

Completed

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

Adult Acute Lymphocytic Leukemia

Germany
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Dasatinib for the Treatment of Moderate and Severe COVID-19

Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Boehringer Ingelheim

Terminated

A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19

COVID-19

United States, Spain
United Therapeutics

Completed

Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE

Pulmonary Hypertension | Interstitial Lung Disease | Combined Pulmonary Fibrosis and Emphysema

United States, Puerto Rico
The University of Texas Health Science Center,...
National Center for Advancing Translational Sciences (NCATS)

Terminated

Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Completed

NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia

Aplastic Anemia | Immunosuppression | Severe Aplastic Anemia | Bone Marrow Failure

United States
AlgiPharma AS
Imperial College London; Cystic Fibrosis Foundation; University Hospital of Cologne and other collaborators

Withdrawn

A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis (SMR3372)

Cystic Fibrosis

Germany
Boehringer Ingelheim

Terminated

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)

Asthma

United States
Boehringer Ingelheim

Terminated

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Asthma

United States
Shanghai Zhongshan Hospital
Ruijin Hospital; The First Affiliated Hospital of Guangzhou Medical University

Completed

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract (PAEAN)

Chronic Obstructive Pulmonary Disease (COPD)

China
Boehringer Ingelheim

Terminated

Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy

Asthma

United States
Kindeva Drug Delivery

Completed

Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate

Healthy

United Kingdom
Boehringer Ingelheim
HealthCore-NERI

Completed

Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]

Pulmonary Disease, Chronic Obstructive

United States
McGill University Health Centre/Research Institute...

Terminated

Inhaled Ciclesonide for Outpatients With COVID19 (CONTAIN)

COVID 19

Canada
Vitality in Aging Research Group, Inc.

Withdrawn

VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements

Aging
UPECLIN HC FM Botucatu Unesp
Chiesi Farmaceutici S.p.A.

Active, not recruiting

Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19 (TRIVID)

Covid19

Brazil
Medical University of Warsaw

Completed

Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma

Asthma | Cough Variant Asthma

Poland
University of California, Los Angeles
Mallinckrodt

Withdrawn

Effect of iNO in Patients With Submassive and Massive PE

Pulmonary Embolism | Pulmonary Embolism Subacute Massive

United States
University of Alberta

Completed

Omental Islet Transplant

Type 1 Diabetes

Canada
Far Eastern Memorial Hospital

Enrolling by invitation

Potential for Inhaled Nitric Oxide and Ventilation-Perfusion Mismatch by Electrical Impedance Tomography in the ARDS Patients With Lung Recruitment

Acute Respiratory Distress Syndrome | Nitric Oxide

Taiwan
Bristol-Myers Squibb

No longer available

Expanded Access for Dasatinib
Ayse Baha

Completed

A Comparison of Classic and Virtual Inhaler Training Methods in COPD Patients

COPD | Inhaler Training | Face-to-face Training | Video-mediated Virtual Training

Turkey
Cameron Dezfulian
Mallinckrodt

Terminated

Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest (iNOOHCA)

Heart Arrest, Out-Of-Hospital

United States
Respira Therapeutics, Inc.

Completed

A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Australia
Tufts Medical Center
Bellerophon

Terminated

Inhaled Nitric Oxide for Preventing Progression in COVID-19 (NO-COVID-19)

COVID-19

United States
Inova Health Care Services

Terminated

Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mercy Research

Terminated

Application of the ICE-T Postoperative Multimodal Pain Regimen to Laparoscopic Hysterectomy

Pain, Postoperative

United States
Boehringer Ingelheim

Completed

A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Korea, Republic of
Engage Therapeutics, Inc.
Clinilabs, Inc.

Completed

Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers

Healthy

United States
Hamad Medical Corporation

Completed

Inhaled Iloprost for Suspected COVID-19 Respiratory Failure (ILOCOVID)

COVID-19 | ARDS, Human | Hypoxemic Respiratory Failure

Qatar
Norwegian School of Sport Sciences

Withdrawn

Can Anti-asthmatic Medication Improve Sprint Performance in Healthy Endurance Athletes?

Sports Drug Abuse
University of Arizona
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Supervised Asthma Medication in Schools (SAMS) (SAMS)

Childhood Asthma

United States
AstraZeneca

Completed

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

Chronic Obstructive Pulmonary Disease (COPD)

Germany
Ottawa Heart Institute Research Corporation
Heart and Stroke Foundation of Ontario

Completed

Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation (STEP)

Smoking Cessation

Canada
Mylan Pharma UK Ltd.

Completed

An Open Study to Assess the Robustness of the CRC749 Inhaler

Asthma | COPD

United Kingdom
Mylan Pharma UK Ltd.

Completed

Bioequivalence Study to Assess Systemic Exposure of FP and SAL FDC From Different DPIs

Asthma | COPD

United States
Washington University School of Medicine

Completed

Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients

Lung Transplant Infection

United States
NYU Langone Health

Withdrawn

Nebulized Furosemide in Premature Infants With Bronchopulmonary Dysplasia - A Cross Over Pilot Study of Its Efficacy and Safety

Premature Birth | Premature Infant

United States
Brown University

Withdrawn

Study of Dasatinib, Androgen Deprivation Therapy and Radiation (BrUOGPR255)

Prostate Cancer
University of Colorado, Denver
University of Southern California; Mannkind Corporation; Atlanta Diabetes Associates and other collaborators

Completed

Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study (STAT)

Diabetes Mellitus, Type 1

United States
ERYtech Pharma

Completed

GRASPA Treatment for Patients With Acute Myeloblastic Leukemia (ENFORCE)

Acute Myeloid Leukemia

France
University of Chicago
American Thoracic Society

Completed

Virtual Teach to Goal vs. Brief Intervention Inhaler Study-outpatient

Asthma in Children

United States
Organon and Co

Withdrawn

Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)

Asthma
Organon and Co

Withdrawn

Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)

Asthma
University Hospital, Bordeaux

Completed

Description of the Ability to Learn How to Handle Inhaler Devices in COPD (INTUITIVE)

Chronic Obstructive Pulmonary Disease (COPD)

France
Organon and Co

Completed

The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)

Asthma
Teva Branded Pharmaceutical Products R&D, Inc.
Parexel

Completed

A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)

Asthma

United States
Organon and Co

Completed

A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524)

Asthma
Organon and Co

Completed

Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)

Asthma, Bronchial

3

Subscribe